Artificial sweeteners do not appear to directly damage the liver the way sugar does, but they aren’t completely off the hook either. A large study published in JAMA found no statistically significant link between artificially sweetened beverages and liver cancer or chronic liver disease mortality, while sugar-sweetened drinks showed a clear association with both. That’s the headline. The details, though, are more nuanced, and some sweeteners raise more concern than others.
Sugar Is the Bigger Liver Threat
The strongest evidence for beverage-related liver harm points squarely at sugar, not artificial sweeteners. Sugar-sweetened drinks drive rapid blood glucose spikes, promote insulin resistance, and accelerate fat accumulation in the liver. In healthy premenopausal women, drinking just one and a half cans of sugar-sweetened beverages per day was associated with liver enzyme levels (ALT and AST) roughly 10 to 14 percent higher than in women who drank less. Elevated liver enzymes are an early marker that the liver is under stress, often from fat buildup.
Fructose is a particular concern. For every additional 10 grams of fructose consumed daily, ALT levels rose about 3 percent. The liver processes fructose almost exclusively, and when it gets more than it can handle, it converts the excess into fat. This process, called hepatic lipogenesis, is the starting point for fatty liver disease.
If you switched from regular soda to a diet version, you likely removed a meaningful source of liver stress. That trade-off matters more than most of the theoretical risks that follow.
How Sweeteners Could Still Affect the Liver
The concern with artificial sweeteners isn’t direct toxicity. It’s a more indirect chain of events that starts in the gut. Several sweeteners, particularly sucralose and acesulfame potassium, alter the composition of gut bacteria in ways that reduce populations of beneficial species. These beneficial microbes normally produce short-chain fatty acids like butyrate, which help maintain the intestinal lining. When those populations shrink, the gut barrier weakens.
A leaky gut allows bacterial toxins, especially one called lipopolysaccharide (LPS), to enter the bloodstream in greater quantities. LPS triggers low-grade inflammation throughout the body, and the liver, which filters blood arriving from the intestines, takes the first hit. In animal studies, sucralose increased the abundance of inflammatory gut bacteria while reducing a key protein that holds intestinal cells tightly together. This combination of gut barrier damage and increased circulating toxins creates conditions that could promote liver inflammation over time.
Animal research on sucralose has also identified a more direct pathway. In mouse studies, long-term sucralose consumption worsened insulin resistance in the liver, particularly when combined with a high-fat diet. The sweetener activated a taste receptor on liver cells that triggered a stress response, promoting fat storage and impairing the liver’s ability to respond to insulin. These effects were dose-dependent and reversible when the receptor was blocked, which strengthens the case that sucralose was the cause rather than a coincidence. Whether these same pathways operate at typical human consumption levels remains unclear.
The Aspartame and Cancer Question
In 2023, the International Agency for Research on Cancer classified aspartame as “possibly carcinogenic to humans,” specifically based on limited evidence linking it to hepatocellular carcinoma, the most common form of liver cancer. This is the third-highest classification out of four levels, and it means the evidence is suggestive but not convincing. Aloe vera and pickled vegetables carry the same classification.
The WHO simultaneously reaffirmed that consuming aspartame within its established safety limit (50 milligrams per kilogram of body weight per day) does not pose a clear cancer risk. For a 150-pound person, that works out to roughly 14 cans of diet soda daily. Most people consume far less.
Erythritol and Liver Fat
Erythritol, a sugar alcohol found in many “natural” zero-calorie sweeteners, has drawn recent attention for a different reason. The liver and kidneys are the main tissues that produce and process erythritol in the body. In people with obesity or insulin resistance, the liver appears to produce more erythritol as a byproduct of excess glucose and fructose metabolism. Elevated blood levels of erythritol have been linked to central adiposity and type 2 diabetes in large cohort studies.
In mice, four weeks of erythritol supplementation increased lipid content in both the liver and muscle tissue while worsening glucose tolerance. However, there’s an important caveat: people with unfavorable metabolic profiles are more likely to choose sugar-free products in the first place, making it difficult to separate cause from effect in human studies. It’s plausible that high erythritol levels in the blood are partly a marker of metabolic dysfunction rather than a cause of it.
Sucralose-6-Acetate: A Breakdown Product Worth Watching
A 2023 study raised a specific concern about sucralose-6-acetate, a compound that exists both as a manufacturing impurity in commercial sucralose (up to 0.67 percent of the product) and as a breakdown product formed when sucralose passes through the intestines. Fecal samples from rodents showed sucralose-6-acetate levels reaching up to 10 percent relative to sucralose itself, suggesting the gut converts a meaningful fraction of what you consume.
In lab tests using human colon tissue, both sucralose and sucralose-6-acetate impaired intestinal barrier integrity. The acetate form also inhibited two liver enzymes in the cytochrome P450 family, which play a role in detoxifying drugs and other foreign compounds. If these enzymes are suppressed, the liver’s ability to process certain medications could be compromised. This research is still early-stage and hasn’t been confirmed in human trials, but it identifies a plausible mechanism for liver-relevant harm.
What the Guidelines Actually Say
The FDA has approved six artificial sweeteners, each with an acceptable daily intake (ADI) calculated to include a wide safety margin. These limits are based on the highest dose that caused no adverse effects in animal studies, then reduced by a safety factor to account for differences between species and individual sensitivity. For common sweeteners, the daily limits per kilogram of body weight are: aspartame at 50 mg, acesulfame potassium at 15 mg, saccharin at 15 mg, and sucralose at 5 mg.
The WHO took a broader stance in 2023, recommending against using non-sugar sweeteners for weight control. Their reasoning was that long-term observational studies consistently associate sweetener use with metabolic syndrome features, including fatty liver disease. However, the WHO acknowledged that this association largely disappears when the data is adjusted for obesity, meaning the sweeteners themselves may not be the primary driver. The recommendation was classified as “conditional,” reflecting genuine uncertainty rather than firm evidence of harm. People with pre-existing diabetes were explicitly excluded from this guidance.
Putting the Risk in Perspective
The overall picture is that artificial sweeteners are far less harmful to the liver than the sugar they replace. No large human study has found a direct link between artificial sweetener consumption and liver cancer or liver disease mortality. The risks that do exist are indirect, operating through gut microbiome changes and potential insulin signaling disruption, and most of the strong evidence comes from animal models using doses higher than typical human intake.
If you’re drinking a few diet sodas per week and otherwise eating a balanced diet, the current evidence does not suggest your liver is at meaningful risk. If you’re consuming large quantities daily, the gut-related effects of sucralose and acesulfame potassium are the most credible concern, and reducing your overall intake of intensely sweet foods and drinks, as the WHO suggests, is a reasonable approach. The best thing you can do for your liver remains straightforward: limit added sugar, maintain a healthy weight, and keep alcohol intake moderate.